145 related articles for article (PubMed ID: 26377659)
21. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.
Ruffini F; Levati L; Graziani G; Caporali S; Atzori MG; D'Atri S; Lacal PM
Oncotarget; 2017 Sep; 8(40):66833-66848. PubMed ID: 28977999
[TBL] [Abstract][Full Text] [Related]
22. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
23. [Nrp-1 expression in healing process of traumatic brain injury combined with tibial fracture].
Li Z; Zhao J; Luo W; Li K; Lei S; Wang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):154-160. PubMed ID: 28255116
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor cell migration by LD22-4, an N-terminal fragment of 24-kDa FGF2, is mediated by Neuropilin 1.
Zhang L; Parry GC; Levin EG
Cancer Res; 2013 Jun; 73(11):3316-25. PubMed ID: 23667176
[TBL] [Abstract][Full Text] [Related]
25. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
26. Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo.
Nasarre C; Roth M; Jacob L; Roth L; Koncina E; Thien A; Labourdette G; Poulet P; Hubert P; Crémel G; Roussel G; Aunis D; Bagnard D
Oncogene; 2010 Apr; 29(16):2381-92. PubMed ID: 20140015
[TBL] [Abstract][Full Text] [Related]
27. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.
Li L; Jiang X; Zhang Q; Dong X; Gao Y; He Y; Qiao H; Xie F; Xie X; Sun X
J Exp Clin Cancer Res; 2016 Jan; 35():16. PubMed ID: 26795388
[TBL] [Abstract][Full Text] [Related]
28. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
29. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
30. Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody.
Ma C; Dou X; Yan J; Wang S; Yang R; Su F; Zhang H; Su X
Anticancer Agents Med Chem; 2019; 19(18):2269-2275. PubMed ID: 31692439
[TBL] [Abstract][Full Text] [Related]
31. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
Man XY; Yang XH; Cai SQ; Yao YG; Zheng M
Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944
[TBL] [Abstract][Full Text] [Related]
32. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Parr MA; Marchenko YY; Eliseev I; Yudenko A; Dobrodumov AV; Zlobina O; Zhakhov A; Ischenko AM; Pitkin E; Multhoff G
J Control Release; 2015 Dec; 220(Pt A):329-340. PubMed ID: 26522072
[TBL] [Abstract][Full Text] [Related]
33. TGF-β as a therapeutic target in high grade gliomas - promises and challenges.
Joseph JV; Balasubramaniyan V; Walenkamp A; Kruyt FA
Biochem Pharmacol; 2013 Feb; 85(4):478-85. PubMed ID: 23159669
[TBL] [Abstract][Full Text] [Related]
34. Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
Vales A; Kondo R; Aichberger KJ; Mayerhofer M; Kainz B; Sperr WR; Sillaber C; Jäger U; Valent P
Leuk Lymphoma; 2007 Oct; 48(10):1997-2007. PubMed ID: 17917967
[TBL] [Abstract][Full Text] [Related]
35. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
Bernatchez PN; Rollin S; Soker S; Sirois MG
J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
[TBL] [Abstract][Full Text] [Related]
36. Application of nanoparticles on diagnosis and therapy in gliomas.
Hernández-Pedro NY; Rangel-López E; Magaña-Maldonado R; de la Cruz VP; del Angel AS; Pineda B; Sotelo J
Biomed Res Int; 2013; 2013():351031. PubMed ID: 23691498
[TBL] [Abstract][Full Text] [Related]
37. Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathway.
Elahouel R; Blanc C; Carpentier G; Frechault S; Cascone I; Destouches D; Delbé J; Courty J; Hamma-Kourbali Y
Neoplasia; 2015 Aug; 17(8):613-24. PubMed ID: 26408254
[TBL] [Abstract][Full Text] [Related]
38. Neuropilin-1 as Therapeutic Target for Malignant Melanoma.
Graziani G; Lacal PM
Front Oncol; 2015; 5():125. PubMed ID: 26090340
[TBL] [Abstract][Full Text] [Related]
39. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells.
Ohsaka A; Hirota-Komatsu S; Shibata M; Komatsu N
Biochem Biophys Res Commun; 2009 Dec; 390(4):1171-6. PubMed ID: 19857463
[TBL] [Abstract][Full Text] [Related]
40. Class 3 semaphorins induce F-actin reorganization in human dendritic cells: Role in cell migration.
Curreli S; Wong BS; Latinovic O; Konstantopoulos K; Stamatos NM
J Leukoc Biol; 2016 Dec; 100(6):1323-1334. PubMed ID: 27406993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
